Forte Biosciences Inc (FBRX) — Financial Flexibility Index
Forte Biosciences Inc (FBRX) has a Financial Flexibility Index of -1.07x as of September 2025. Free cash flow of $-13.95 Million (operating CF $-14.00 Million minus capex $55.00K) represents -1% of total liabilities ($12.99 Million). Check Forte Biosciences Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Forte Biosciences Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Forte Biosciences Inc across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Forte Biosciences Inc.
Annual Financial Flexibility Index for Forte Biosciences Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Forte Biosciences Inc. Explore FBRX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.38x | $-30.71 Million | $-30.75 Million | $9.08 Million | ▲ +56.7% |
| 2023 | -7.81x | $-28.62 Million | $-28.71 Million | $3.67 Million | ▼ -203.2% |
| 2022 | -2.57x | $-8.19 Million | $-8.19 Million | $3.18 Million | ▲ +72.8% |
| 2021 | -9.45x | $-16.62 Million | $-16.68 Million | $1.76 Million | ▼ -15.9% |
| 2020 | -8.16x | $-18.42 Million | $-18.42 Million | $2.26 Million | ▼ -497.7% |
| 2019 | -1.36x | $-2.61 Million | $-2.77 Million | $1.91 Million | ▼ -88.7% |
| 2018 | -0.72x | $-32.50 Million | $-34.47 Million | $44.94 Million | ▲ +50.2% |
| 2017 | -1.45x | $-30.48 Million | $-31.13 Million | $20.99 Million | ▼ -41.9% |
| 2016 | -1.02x | $-29.01 Million | $-29.54 Million | $28.36 Million | ▼ -13.5% |
| 2015 | -0.90x | $-20.81 Million | $-21.04 Million | $23.09 Million | — |